Llovet JM, Zucman-Rossi J, Pikarsky E et al. Hepatocellular carcinoma. Nature Reviews Disease Primers 2016;2:16018.

Article  PubMed  Google Scholar 

Ferlay J, Soerjomataram I, Dikshit R et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359-386.

Article  CAS  PubMed  Google Scholar 

Reig M, Forner A, Rimola J et al. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update. J Hepatol 2022;76:681–693.

Article  PubMed  Google Scholar 

Singal AG, Llovet JM, Yarchoan M et al. AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology 2023;78:1922–1965.

Article  PubMed  Google Scholar 

Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet 2018;391:1301–1314.

Article  PubMed  Google Scholar 

Lencioni R. Management of hepatocellular carcinoma with transarterial chemoembolization in the era of systemic targeted therapy. Crit Rev Oncol Hematol 2012;83:216–224.

Article  PubMed  Google Scholar 

Ho S-Y, Liu P-H, Hsu C-Y et al. Surgical resection versus transarterial chemoembolization for patients with hepatocellular carcinoma beyond Milan criteria: prognostic role of tumor burden score. Sci Rep 2023;13:13871.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lambin P, Rios-Velazquez E, Leijenaar R et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer 2012;48:441–446.

Article  PubMed  PubMed Central  Google Scholar 

Zhou PC, Sun LQ, Shao L, Yi LZ, Li N, Fan XG. Establishment of a pattern recognition metabolomics model for the diagnosis of hepatocellular carcinoma. World J Gastroenterol 2020;26:4607–4623.

Article  PubMed  PubMed Central  Google Scholar 

Esteva A, Chou K, Yeung S et al. Deep learning-enabled medical computer vision. NPJ Digit Med 2021;4:5.

Article  PubMed  PubMed Central  Google Scholar 

Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nat Med 2019;25:44–56.

Article  CAS  PubMed  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71.

Article  PubMed  PubMed Central  Google Scholar 

Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 2014;14:135.

Article  PubMed  PubMed Central  Google Scholar 

Choi SJ, Kim J, Seo J, Kim HS, Lee J-M, Park H. Parametric response mapping of dynamic CT as an imaging biomarker to distinguish viability of hepatocellular carcinoma treated with transcatheter arterial chemoembolization. Abdominal Imaging 2014;39:518–525.

Article  PubMed  Google Scholar 

Choi SJ, Kim J, Seo J, Kim HS, Lee J-M, Park H. Parametric response mapping of dynamic CT for predicting intrahepatic recurrence of hepatocellular carcinoma after conventional transcatheter arterial chemoembolization. Eur Radiol 2016;26:225–234.

Article  PubMed  Google Scholar 

Choi SJ, Kim J, Kim HS, Park H. Parametric response mapping of dynamic CT: enhanced prediction of survival in hepatocellular carcinoma patients treated with transarterial chemoembolization. Abdominal Radiol 2017;42:1871–1879.

Article  Google Scholar 

Kloth C, Thaiss WM, Kärgel R et al. Evaluation of texture analysis parameter for response prediction in patients with hepatocellular carcinoma undergoing drug-eluting bead transarterial chemoembolization (DEB-TACE) using biphasic contrast-enhanced CT image data: correlation with liver perfusion CT. Academic Radiol 2017;24:1352–1363.

Article  Google Scholar 

Park HJ, Kim JH, Choi S-Y et al. Prediction of therapeutic response of hepatocellular carcinoma to transcatheter arterial chemoembolization based on pretherapeutic dynamic CT and textural findings. AJR Am J Roentgenol 2017;209:W211–W220.

Article  PubMed  Google Scholar 

Kim J, Choi SJ, Lee S-H, Lee HY, Park H. Predicting survival using pretreatment CT for patients with hepatocellular carcinoma treated with transarterial chemoembolization: comparison of models using radiomics. AJR American journal of roentgenology 2018;211:1026–1034.

Article  PubMed  Google Scholar 

Khalaf AM, Fuentes D, Morshid A et al. Hepatocellular carcinoma response to transcatheter arterial chemoembolisation using automatically generated pre-therapeutic tumour volumes by a random forest-based segmentation protocol. Clinical Radiology 2019;74:974.e913-974.e920.

Article  Google Scholar 

Morshid A, Elsayes KM, Khalaf AM et al. A machine learning model to predict hepatocellular carcinoma response to transcatheter arterial chemoembolization. Radiology: Artificial Intelligence 2019;1:e180021.

PubMed  PubMed Central  Google Scholar 

Meng XP, Wang YC, Ju S et al. Radiomics analysis on multiphase contrast-enhanced CT: a survival prediction tool in patients with hepatocellular carcinoma undergoing transarterial chemoembolization. Frontiers in Oncology. 2020. https://doi.org/10.3389/fonc.2020.01196.

Article  PubMed  PubMed Central  Google Scholar 

Peng J, Kang S, Ning Z et al. Residual convolutional neural network for predicting response of transarterial chemoembolization in hepatocellular carcinoma from CT imaging. European Radiology 2020;30:413–424.

Article  PubMed  Google Scholar 

Moawad AW, Fuentes D, Khalaf AM et al. Feasibility of automated volumetric assessment of large hepatocellular carcinomas’ responses to transarterial chemoembolization. Frontiers in Oncology. 2020. https://doi.org/10.3389/fonc.2020.00572.

Article  PubMed  PubMed Central  Google Scholar 

Boldanova T, Fucile G, Vosshenrich J et al. Supervised learning based on tumor imaging and biopsy transcriptomics predicts response of hepatocellular carcinoma to transarterial chemoembolization. Cell Reports Medicine. 2021. https://doi.org/10.1016/j.xcrm.2021.100444.

Article  PubMed  PubMed Central  Google Scholar 

Chen M, Cao J, Hu J et al. Clinical-radiomic analysis for pretreatment prediction of objective response to first transarterial chemoembolization in hepatocellular carcinoma. Liver Cancer. 2021;10:38–51.

Article  PubMed  PubMed Central  Google Scholar 

Guo Z, Zhong N, Xu X et al. Prediction of hepatocellular carcinoma response to transcatheter arterial chemoembolization: A real-world study based on non-contrast computed tomography radiomics and general image features. Journal of Hepatocellular Carcinoma 2021;8:773–782.

Article  PubMed  PubMed Central  Google Scholar 

Mao X, Guo Y, Wen F, Liang H, Sun W, Lu Z. Applying arterial enhancement fraction (AEF) texture features to predict the tumor response in hepatocellular carcinoma (HCC) treated with transarterial chemoembolization (TACE). Cancer Imaging. 2021. https://doi.org/10.1186/s40644-021-00418-2.

Article  PubMed  PubMed Central  Google Scholar 

Niu XK, He XF. Development of a computed tomography-based radiomics nomogram for prediction of transarterial chemoembolization refractoriness in hepatocellular carcinoma. World Journal of Gastroenterology. 2021;27:189–207.

Article  PubMed  PubMed Central  Google Scholar 

Sheen H, Kim JS, Lee JK, Choi SY, Baek SY, Kim JY. A radiomics nomogram for predicting transcatheter arterial chemoembolization refractoriness of hepatocellular carcinoma without extrahepatic metastasis or macrovascular invasion. Abdominal Radiology. 2021;46:2839–2849.

Article  PubMed  Google Scholar 

Tipaldi MA, Ronconi E, Lucertini E et al. Hepatocellular carcinoma drug-eluting bead transarterial chemoembolization (Deb-tace): outcome analysis using a model based on pre-treatment ct texture features. Diagnostics 2021;11:956.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vosshenrich J, Zech CJ, Heye T et al. Response prediction of hepatocellular carcinoma undergoing transcatheter arterial chemoembolization: unlocking the potential of CT texture analysis through nested decision tree models. European Radiology 2021;31:4367–4376.

Article  PubMed